Explore 4-HO-DET | PiHKAL

TiHKAL book II entry 4-HO-DET

ChemSpider 8167136
PubChem 9991554
Wikidata Q4637139
Erowid 4-HO-MET
Wikipedia 4-HO-DET
Blotter 4-HO-DET
PsychonautWiki 4-HO-DET
Trout’s Notes CZ-74. In Some Simple Tryptamines, 2nd ed., pp. 88–94
Project Response 4-HO-DET (3019-21)
swgdrug.org 4-Hydroxy-DET
bluelight.org The Big & Dandy 4-HO-DET Thread
Rhodium Psychedelic chemistry by M. V. Smith, chapter 3

TiHKAL #15 4-HO-DBT · #17 4-HO-DIPT · #18 4-HO-DMT · #20 4-HO-DPT · #21 4-HO-MET · #22 4-HO-MIPT · #23 4-HO-MPT · #24 4-HO-pyr-T · #40 5-MeO-MIPT

Repke, DB; Ferguson, WJ; Bates, DK. Psilocin analogs. 1. Synthesis of 3-[2-(dialkylamino)ethyl]- and 3-[2-(cycloalkylamino)ethyl]indol-4-ols. J. Heterocycl. Chem., 1 Jan 1977, 14 (1), 71–74. 273 kB. https://doi.org/10.1002/jhet.5570140113 #4a NMR

Meyers-Riggs, B. 4-Hydroxy tryptamines. countyourculture, countyourculture: rational exploration of the underground, 7 Jul 2012.

Meyers-Riggs, B. Biosynthesis of 4-substituted tryptamine derivatives. countyourculture, countyourculture: rational exploration of the underground, 17 Feb 2012.

McKenna, DJ; Repke, DB; Lo, L; Peroutka, SJ. Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology, 1 Mar 1990, 29 (3), 191–198. 679 kB. https://doi.org/10.1016/0028-3908(90)90001-8

Chapman, SJ. PeakAL: Protons I Have Known and Loved, Too — Another Fifty Shades of Grey-Market Spectra. BLOTTER, 1 Mar 2018, 3 (1). 1.2 MB. https://doi.org/10.16889/isomerdesign-5

Chapman, SJ. PeakAL: Protons I Have Known and Loved, Too — Another Fifty Shades of Grey-Market Spectra. Supplementary Data. BLOTTER, 1 Mar 2018, 3 (1). 5.7 MB. https://doi.org/10.16889/isomerdesign-5-supp

Uchiyama, N; Kawamura, M; Kikura-Hanajiri, R; Goda, Y. URB-754: A new class of designer drug and 12 synthetic cannabinoids detected in illegal products. Forensic Sci. Int., 10 Apr 2013, 227 (1), 21-32. 1.8 MB. https://doi.org/10.1016/j.forsciint.2012.08.047 #XVI

Zhang, S; Fan, Y; Shi, Z; Cheng, S. DFT-based QSAR and action mechanism of phenylalkylamine and tryptamine hallucinogens. Chin. J. Chem., 1 Apr 2011, 29 (4), 623–630. 166 kB. https://doi.org/10.1002/cjoc.201190132 #66

Nichols, DE. Chemistry and structure–activity relationships of psychedelics. In Behavioral Neurobiology of Psychedelic Drugs; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 1 Jan 2017; pp 1-43. 2.6 MB. https://doi.org/10.1007/7854_2017_475 #16

Jacob, P; Shulgin, AT. Structure-activity relationships of the classic hallucinogens and their analogs. In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1994; pp 74–91. 51 kB.

Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.

Shulgin, AT. Hallucinogens. In Burger’s Medicinal Chemistry, 4th ed., Part III; Wolff, ME, Ed., John Wiley & Sons, Inc., 1 Jan 1981; pp 1109–1137. 4.7 MB. #29g

Shulgin, AT. Chemistry of psychotomimetics. In Handbook of Experimental Pharmacology. Psychotropic Agents, Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs; Hoffmeister, F; Stille, G, Eds., Springer-Verlag, Berlin, 1 Jan 1982; Vol. 55 (3), pp 3–29. 928 kB. https://doi.org/10.1007/978-3-642-67770-0_1 #4h

Shulgin, AT. Psychotomimetic agents. In Psychopharmacological Agents; Gordon, M, Ed., Academic Press, New York, 1 Jan 1976; Vol. 4, pp 59–146. 3.1 MB. #XXXIV

EMCDDA. New drugs in Europe, 2005, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2006. 1.2 MB. #4-HO-DET

Fricke, J; Lenz, C; Wick, J; Blei, F; Hoffmeister, D. Production options for psilocybin: Making of the magic. Chem. Eur. J., 18 Jan 2019, 25 (4), 897–903. 1.8 MB. https://doi.org/10.1002/chem.201802758 #17.5

Halberstadt, AL; Chatha, M; Klein, AK; Wallach, J; Brandt, SD. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology, 1 May 2020, 167, 107933. 2.4 MB. https://doi.org/10.1016/j.neuropharm.2019.107933 #4-HO-DET

Sexton, JD; Nichols, CD; Hendricks, PS. Population survey data informing the therapeutic potential of classic and novel phenethylamine, tryptamine, and lysergamide psychedelics. Front. Psychiatry, 11 Feb 2020, 10 (896). 529 kB. https://doi.org/10.3389/fpsyt.2019.00896 #4-HO-DET

Klein, AK; Chatha, M; Laskowski, LJ; Anderson, EI; Brandt, SD; Chapman, SJ; McCorvy, JD; Halberstadt, AL. Investigation of the structure–activity relationships of psilocybin analogues. ACS Pharmacol. Transl. Sci., 9 Apr 2021, 4 (2), 533-542. 1.9 MB. https://doi.org/10.1021/acsptsci.0c00176 #4-HO-DET

Doi, K; Miyazawa, M; Fujii, H; Kojima, T. The analysis of the chemical drugs among structural isomer. Yakugaku Zasshi, 1 Sep 2006, 126 (9), 815–823. 371 kB. https://doi.org/10.1248/yakushi.126.815 #4HO-DET GC,LC,MS,NMR,IR,TLC

Glennon, RA; Rosecrans, JA. Indolealkylamine and phenalkylamine hallucinogens: A brief overview. Neurosci. Biobehav. Rev., 1 Jan 1982, 6 (4), 489–497. 895 kB. https://doi.org/10.1016/0149-7634(82)90030-6 #4b

McKenna, DJ; Towers, HHN. Biochemistry and pharmacology of tryptamines and beta-carbolines: A minireview. J. Psychoactive Drugs, 1 Jan 1984, 16 (4), 347–358. 10.8 MB. https://doi.org/10.1080/02791072.1984.10472305 #CZ-74

Gartz, J. Biotransformation of tryptamine derivatives in mycelia cultures of Psilocybe. J. Basic. Microbiol., 1 Jan 1989, 29 (6), 347–352. 357 kB. https://doi.org/10.1002/jobm.3620290608 #HT

Glatfelter, GC; Naeem, M; Pham, DNK; Golen, JA; Chadeayne, AR; Manke, DR; Baumann, MH. Receptor binding profiles for tryptamine psychedelics and effects of 4-propionoxy-N,N-dimethyltryptamine in mice. ACS Pharmacol. Transl. Sci., 14 Apr 2023, 6 (4), 567–577. 2.0 MB. https://doi.org/10.1021/acsptsci.2c00222 #4-HO-DET

4-HO-MIPT · 4-Hydroxy-N-methyl-N-isopropyltryptamine

4-HO-MPT · 4-Hydroxy-N-methyl-N-propyltryptamine

2-Methyl-5-MeO-DMT · 2-Methyl-5-methoxy-N,N-dimethyltryptamine · 5-MeO-TMT · 5-Methoxy-2-methyl-DMT · MMDT

6-HO-DET · 6-Hydroxy-N,N-diethyltryptamine

5-EtO-DMT · 5-Ethoxy-N,N-dimethyltryptamine · 5-Ethoxy-DMT

7-MeO-NIPT · 7-Methoxy-N-isopropyltryptamine

6-Methyl-5-MeO-DMT · 6-Methyl-5-methoxy-N,N-dimethyltryptamine · 6-Methylbufotenin

5-MeO-α-methyl-DMT · 5-Methoxy-α-methyl-N,N-dimethyltryptamine

1-Isopropyl-5-MeO-T · 1-Isopropyl-5-methoxytryptamine

5-MeO-MET · 5-Methoxy-N-methyl-N-ethyltryptamine

PZAP

5-MeO-NIPT · 5-Methoxy-N-isopropyltryptamine

7-Methyl-5-MeO-DMT · 7-Methyl-5-methoxy-N,N-dimethyltryptamine

1-Methyl-5-MeO-DMT · 1-Methyl-5-methoxy-N,N-dimethyltryptamine

5-PrO-NMT · 5-Propoxy-N-methyltryptamine

5-IPrO-NMT · 5-Isopropoxy-N-methyltryptamine

10613

8-MeO-THPQ

Norfentanyl

N-Methyl-acetyl-norfentanyl

5-HO-MIPT · 5-Hydroxy-N-methyl-N-isopropyltryptamine

12136

4-Hydroxyethyl-N,N-dimethyltryptamine · 4-Hydroxyethyl-DMT

N,N-Diethyltryptamine N-oxide · DET N-oxide

4-HO-NTBT · 4-Hydroxy-N-tert-butyltryptamine

4-HO-NSBT · 4-Hydroxy-N-sec-butyltryptamine

α-HO-DET · α-Hydroxy-N,N-diethyltryptamine

5-MeO-α-methyl-iso-DMT · 5-Methoxy-α-methyl-N,N-dimethyl-isotryptamine · AAZ-A-154

5-IPrO-AMT · 5-Isopropoxy-α-methyltryptamine

4-Methyl-5-MeO-DMT · 4-Methyl-5-methoxy-N,N-dimethyltryptamine

5-HO-DET · 5-Hydroxy-N,N-diethyltryptamine

p4-462: α-CP-2C-D; 2C-C; 4-HO-DET; 4-HO-DPT; 4-MeO-DET; 5,6-MDO-MIPT; BOAD; BOD; DMA; DOIB; DPT; ORTHO-MDA